Literature DB >> 8811851

Characterization of the parasite-host cell interactions involved in Theileria parva sporozoite invasion of bovine lymphocytes.

M K Shaw1.   

Abstract

Sporozoite invasion of bovine lymphocytes by Theileria parva is a pH-dependent process that occurs without the need for de novo protein synthesis. The process was inhibited by RGD(S) peptides, fibronectin and, in the presence of serum, by antibodies reactive with fibronectin. Invasion was also blocked by a range of sulphated glycoconjugates, but treatment of lymphocytes with heparitinase did not inhibit entry. Enzymic modifications of the lymphocyte surface demonstrated that trypsin-insensitive glycoproteins containing O- and N-linked carbohydrates as well as phospholipase-sensitive molecules on the host cell surface were critical to sporozoite entry. Modification of the lymphocyte surface with NEM and DTT had only marginal effects on sporozoite binding but blocked parasite internalization. Invasion was also blocked by several antibodies which cross-reacted with sporozoite surface molecules. While only a few experimental conditions specifically blocked sporozoite binding, a wider range of reagents and treatments inhibited parasite entry. The reasons for this are discussed in terms of the nature of the zippering process that facilitates sporozoite internalization.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8811851     DOI: 10.1017/s0031182000082032

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  2 in total

1.  Theileria parva: in vitro studies on the effects of holding temperature, pH and medium on sporozoite infectivity.

Authors:  E N Kimbita; R S Silayo; T T Dolan
Journal:  Trop Anim Health Prod       Date:  2004-05       Impact factor: 1.559

Review 2.  The Complexity of Piroplasms Life Cycles.

Authors:  Marie Jalovecka; Ondrej Hajdusek; Daniel Sojka; Petr Kopacek; Laurence Malandrin
Journal:  Front Cell Infect Microbiol       Date:  2018-07-23       Impact factor: 5.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.